Impact assessment of WHO TobReg proposals for mandated lowering of selected mainstream cigarette smoke toxicants

Regulatory Toxicology and Pharmacology

Volumn 86, Issue , 2017, Pages 332-348

  Eldridge, Alison C ^a   McAdam, Kevin G ^a   Betson, Tatiana R ^a   Gama, Marcos V ^a   Proctor, Christopher J ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Ceilings; Cigarette; Emissions; Regulation; Smoke; TobReg; Toxicants

Indexed keywords

CIGARETTE SMOKE; NICOTINE; NITROSAMINE;

ARTICLE; CONTROLLED STUDY; GOVERNMENT REGULATION; HEALTH IMPACT ASSESSMENT; HUMAN; RISK ASSESSMENT; SMOKING; SMOKING CESSATION PROGRAM; SMOKING REGULATION; TOXICITY TESTING; ANALYSIS; CHEMISTRY; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; SMOKE; TOBACCO; TOXICITY; WORLD HEALTH ORGANIZATION;

INTERNATIONALITY; NICOTINE; NITROSAMINES; SMOKE; TOBACCO; TOBACCO PRODUCTS; WORLD HEALTH ORGANIZATION;

EID: 85017175391     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2017.02.022     Document Type: Article

References (32)

1. ANVISA, Brazil Resolution RDC No. 90 of the Federal Sanitation Agency Effective 27. 2007 December 2007 (re-published) www.anvisa.gov.br.
2. AOAC International, Appendix K: Guidelines for Dietary Supplements and Botanicals, Part 1 AOAC Guidelines for Single-Laboratory Validation of Chemical Methods for Dietary Supplements and Botanicals. 2013 (Accessed 13 April 2017) http://www.eoma.aoac.org/app_k.pdf.
3. Burns, D.M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O'Connor, R., Djordjevic, M., Dresler, C., Hainaut, P., Jarvis, M., Opperhuizen, A., Straif, K., Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 2008:17 (2008), 132–141, 10.1136/tc.2007.024158.
4. Camacho, O.M., Eldridge, A., Proctor, C.J., McAdam, K., Empirical characterisation of ranges of mainstream smoke toxicant yields from contemporary cigarette products using quantile regression methodology. Regul. Toxicol. Pharmacol., 12(3), 2015, 10.1016/j.yrtph.2015.05.023.
5. Counts, M.E., Morton, M.J., Laffoon, S.W., Cox, R.H., Lipowicz, P.J., Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 41:3 (2005), 185–227.
6. Czoli, C., Hammond, D., TSNA Exposure: levels of NNAL among Canadian tobacco users. Nicotine Tob. Res. 17:7 (2015), 825–830.
7. Eldridge, A., Betson, T.R., Vinicius Gama, M., McAdam, K., Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products. Regul. Toxicol. Pharmacol. 71 (2015), 409–427.
8. FDA, Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List. 2012, US Food and Drug Administration http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297786.htm.
9. Gaworski, C.L., Wagner, K., Morton, M.J., Oldham, M.J., Insights from a multi-year program designed to test the impact of ingredients on mainstream cigarette smoke toxicity. Inhal. Toxicol. 23:s1 (2011), 172–183, 10.3109/08958378.2010.546440.
10. Gray, N., Boyle, P., The case of the disappearing nitrosamines: a potentially global phenomenon. Tob. Control 13:1 (2004), 13–16.
11. Health Canada, Tobacco Reporting Regulations SOR/2000-273. Published, 2000 (Accessed April 2014) http://laws-lois.justice.gc.ca.
12. Health Canada, Constituents and Emissions Reported for Cigarettes Sold in Canada., 2004 Unpublished data received on request from TRR_RRRT@hc-sc.gc.ca.
13. Hyodo, T., Inoue, O., Katagiri, H., Mikita, A., Fujiwara, M., Long-term Inter-laboratory Comparisons of Selected Analytes in 2R4F Mainstream Smoke, 2006 CORESTA Conference Paper SS7.
14. IARC, Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum. 83 (2004), 1–1438 PMID:15285078.
15. Intorp, M., Purkiss, S., Whittaker, M., Wright, W., Determination of ‘Hoffmann Analytes' in cigarette mainstream smoke. The CORESTA 2006 joint experiment. Beit. Tab. Intl. 23 (2009), 161–202.
16. International Organization for Standardization ISO5725–2, Accuracy (Trueness and Precision) of Measurements Methods and Results – Part 2. Basic Method for Determination of Repeatability and Reproducibility of a Standard Measurement Method. 1994, ISO, Geneva 1994.
17. International Organization for Standardization ISO 8243, Cigarettes – Sampling. 2013, ISO, Geneva 2013.
18. Liu, C., Perfetti, T., McADam, K., Some recent topics in cigarette smoke science. Mini-Reviews Org. Chem. 8:4 (2011), 349–359, 10.2174/157019311797440272.
19. Morton, M.J., Laffoon, S.W., Cigarette smoke chemistry market maps under massachusetts department of public health smoking conditions. Regul. Toxicol. Pharmacol. 51 (2008), 1–30.
20. Oldham, M.J., Desoi, D.J., Rimmer, L.T., Wagner, K.A., Morton, M.J., Insights from analysis for harmful and potentially harmful constituents (HPHCs) in tobacco products. Regul. Toxicol. Pharmacol. 70:1 (2014), 138–148, 10.1016/j.yrtph.2014.06.017.
21. Purkis, S., Intorp, M., Analysis of reference cigarette smoke yield data from 21 laboratories for 28 selected analytes as a guide to selection of new CORESTA recommended methods. Beit. Tab. Intl. 26:2 (2014), 57–73.
22. Shepperd, C.J., Eldridge, A., Camacho, O.M., McAdam, K., Proctor, C., Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes. Regul. Toxicol. Pharmacol. 66 (2013), 147–162.
23. Stratton, Kathleen, Shetty, Padma, Wallace, Robert, Bondurant, Stuart, editors, Clearing the smoke: the science base for tobacco harm reduction—executive. Tob. Control 10 (2001), 189–195.
24. Taiwan, 2010, http://www.health99.doh.gov.tw/box2/smokefreelife/law.aspx, (Accessed 14 June 2010).
25. Teillet, B., Cahours, X., Verron, T., Colard, S., Purkis, S., Comparison of smoke yield data collected from different laboratories. Beit. Tab. Intl. 25:8 (2013), 662–670.
26. U.S. Department of Health and Human Services, The Health Consequences of Smoking— 50 Years of Progress: A Report of the Surgeon General. 2014, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
27. World Health Organization, WHO Framework Convention on Tobacco Control. 2005, WHO, Geneva ISBN 978 92 4 159101 0; whqlibdoc.who.int/publications/2003/9241591013.pdf.
28. World Health Organization, The Scientific Basis of Tobacco Product Regulation. WHO Technical Report Series 951., 2008, WHO, Geneva.
29. World Health Organization, WHO Report on the Global Tobacco Epidemic, 2011: Warning about the Dangers of Tobacco., 2011, WHO, Geneva.
30. World Health Organisation, Report on the Scientific Basis of Tobacco Product Regulations: Fifth Report of a WHO Study Group. WHO Technical Report Series 989., 2015, WHO, Geneva.
31. World Health Organization, Tobacco- Fact Sheet No339, June 2016. 2016 (Accessed 16 January 2017) http://www.who.int/mediacentre/factsheets/fs339/en/.
32. World Health Organisation (2016b). http://www.who.int/fctc/signatories_parties/en/(Accessed 16 January 2017).